GlucoLight

GlucoLight was a medical device company that specialized in the development of non-invasive glucose monitoring technology for individuals with diabetes. The company's proprietary platform utilized Optical Coherence Tomography (OCT) to measure glucose levels through the skin, offering a painless alternative to traditional finger-stick blood tests. Their primary product under development was the Sentris monitoring system, designed for use in clinical and home settings to provide frequent glucose readings. In 2010, GlucoLight was acquired by LifeScan, a Johnson & Johnson company, to integrate its optical sensing technology into the broader J&J diabetes care franchise.